29 results
8-K
PTPI
Petros Pharmaceuticals Inc
28 Dec 23
Departure of Directors or Certain Officers
4:05pm
will vest upon the achievement of certain strategic goals during 2023 and 2024, provided that Mr. Boctor remains employed by the Company on the applicable
424B3
PTPI
Petros Pharmaceuticals Inc
19 Sep 23
Prospectus supplement
4:36pm
to pursue out strategic goals, including our Non-Prescription / OTC strategies related to Stendra®. If we do not obtain any such additional financing … , it may be difficult to effectively realize our long-term strategic goals and objectives.
Our current cash resources will not be sufficient to fund
POS AM
mkcp8iju9fn1n
14 Oct 22
Prospectus update (post-effective amendment)
4:05pm
PRE 14A
7as y57o746n
30 Sep 22
Preliminary proxy
4:45pm
424B3
fdjab3uq 7xuq54e1eg
14 Jan 22
Prospectus supplement
5:18pm
424B5
up444t6hdbh82tmtf
23 Dec 21
Prospectus supplement for primary offering
5:01pm
424B5
soh8o dbhp5
1 Dec 21
Prospectus supplement for primary offering
5:10pm
DEF 14A
psxnd
22 Nov 21
Definitive proxy
4:37pm